Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 498

Results For "MIT"

5636 News Found

AIIMS now uses ImmersiveTouch for surgeries
Digitisation | January 14, 2022

AIIMS now uses ImmersiveTouch for surgeries

Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training


U.S. FDA approves treatment to control pain in cats with osteoarthritis
Drug Approval | January 14, 2022

U.S. FDA approves treatment to control pain in cats with osteoarthritis

It is the first monoclonal antibody drug for use in any animal species


Glenmark receives U.S. FDA approval for Ryaltris
Drug Approval | January 14, 2022

Glenmark receives U.S. FDA approval for Ryaltris

The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily


LumiraDx Lab Covid-19 Antigen test detects the Omicron variant
Medical Device | January 14, 2022

LumiraDx Lab Covid-19 Antigen test detects the Omicron variant

In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants


South Korea approves Novavax Covid-19 vaccine
Drug Approval | January 13, 2022

South Korea approves Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea


Metropolis Healthcare opens MedEngage Scholarship programme
News | January 13, 2022

Metropolis Healthcare opens MedEngage Scholarship programme

The last date to apply for this program is 18th January 2022


Cipla wins Frost & Sullivan and Teri Sustainability award for `Challenger in Mega Large Business Pharma Sector’
Sustainability | January 13, 2022

Cipla wins Frost & Sullivan and Teri Sustainability award for `Challenger in Mega Large Business Pharma Sector’

The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People


AstraZeneca studies show its booster effective against all variants
News | January 13, 2022

AstraZeneca studies show its booster effective against all variants

New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria


AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons
Medical Device | January 13, 2022

AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales


Merck KGaA appoints Global R&D Head & CSO for healthcare business sector
People | January 13, 2022

Merck KGaA appoints Global R&D Head & CSO for healthcare business sector

Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer